Abstract
Surgical pathology of lung diseases involves one of the most critical organs in the human body. The major conditions studied in lung pathology include inflammatory, autoimmune, infectious, and neoplastic diseases. The pulmonary pathologist works closely with radiologist, pulmonologists, and thoracic surgeon in the diagnosis and management of difficult and challenging cases of lung diseases. In the area of inflammatory lung diseases, the radiologist has a major role in establishing the diagnosis, especially if the pathologist has only a needle biopsy of lung tissue. Classification of neoplastic lung diseases is done mainly by the pathologist, since microscopic examination is needed to classify these neoplasms. Some of these diseases include bacterial pneumonia, viral pneumonia such as influenza, severe respiratory syndrome, Middle East respiratory syndrome, and COVID-19, as well as interstitial pulmonary fibrosis. Neoplastic diseases include squamous carcinomas, adenocarcinomas, neuroendocrine tumors, and mesotheliomas.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bartlett JG, Breiman RF, Mandell LA, et al. Community acquired pneumonia in adults. Guideline for management. The infectious disease Society of America. Clin Inf Dis. 1998;26:811–38.
Henig O, Kaye KS. Bacterial pneumonia in older adults. Inf Dis Clin North Am. 2017;31(4):684–713.
Ruuskanen O, Lahti E, Jennings LC, et al. Viral pneumonia. Lancet. 2011;377(9773):1264–75.
Taubenberger JK, Morens DM. The pathology of influenza virus infections. Ann Rev Pathol. 2008;3:499–522.
Umakantham S, Sahu P, Raviade AV, et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J. 2020;96(142):753–8.
Merad M, Blish CA, Sallusto F, et al. The immunology and immunopathology of COVID-19. Science. 2022;375(6585):1122–7.
Borczuk AC, Salvatore SP, Seshan SV, et al. COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City. Mod Pathol. 2020;33(1):2156–68.
Lederer DJ, Martinez FJ. Idiopathic pulmonary fibrosis. N Engl J Med. 2018;378:1811–23.
Sack C, Raghu G. Idiopathic pulmonary fibrosis: unmasking cryptogenic environmental factors. Eur Respir J. 2019;53(2):1801699. https://doi.org/10.1183/13993003.01699-2018.
Wolters PJ, Collard HR, Jones KD. Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol. 2014;9:157–79.
Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.
Sholl LM. The molecular pathology of lung cancer. Surgical Pathology Clinics. 2016;9(3):353–78.
Huang G, Zhang J, Gong L, et al. Specific lung squamous cell carcinoma. Prognosis-subtype distinction based on DNA methylation patterns. Med Sci Monit. 2021;27:e929524. https://doi.org/10.12659/MSM.929524.
Succony DM, Rassl DM, Barker AP, et al. Adenocarcinoma spectrum lesions of the lung: detection, pathology and treatment strategies. Cancer Treat Rev. 2021;99:102237.
Sakamoto H, Shimazu J, Horio Y, et al. Disproportionate representation of KRAS gene mutations in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutations from preinvasive and invasive adenocarcinoma. J Pathol. 2007;212(3):287–94.
Randhawa S, Trikalinos N, Patterson GA. Neuroendocrine tumors of the lung. Thorac Surg Clin. 2021;31(4):469–76.
Rindi G, Klimstra DS, Abedi-Andekavu B, et al. A common classification framework for neuroendocrine neoplasms. An international Agency for Research on Cancer (IAAC) and World Health Organization (WHO) expert consensus proposal. Modern Pathol. 2018;31(12):1770–86.
Metovic J, Barella M, Bianchi F, et al. Morphological and molecular classification of lung neuroendocrine neoplasms. Virchows Arch. 2021;478(1):5–19.
Raso MG, Bota-Rabbasedas N, Wistuba II. Pathology and classification of SCLC Cancers. 2021;13(4):820.
Beasley MB, Galateau Salle F, Dacic S. Pleural mesothelioma classification update. Virchows Arch. 2021;478:59–72.
Hung UP, Chirieac LR. Pathology of malignant pleural mesothelioma. Thor Surg Clinic. 2020;30(4):367–82.
Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med. 2005;353:1591–603.
Tighe JR. Herbert Spenser Obituary(1915–1993). British Med J. 1993;307:378.
Harley RA. Liebow, Averill Abraham (1911–1978). In: van den Tweel JG, editor. Pioneers in pathology. In: van Krieken JHJM, series editor. Encyclopedia of pathology. Cham:Springer; 2017. p. 340–44.
Bloor CM. In remembrance of Avil A. Liebow. March 31, 1911-May 3,1978. Am J Pathol. 1978;92(3):577–80.
Smith GJ. Averill Abraham Liebow contributions to pulmonary pathology. Yale J Biol Med. 1981;54(2):139–46.
Liebow AA. Tumors of the lower respiratory tract. In: Atlas of tumor pathology. Washington DC: Armed Forces Institute of Pathology; 1952.
Liebow AA, Steer B, Billingsley AJ. Desquamative interstitial pneumonia. Am J Medicine. 1965;39:369–404.
Katzenstein AL, Carrington CB, Liebow AA, Lymphomatoid granulomatosis. A clinicopathologic study of 152 cases. Cancer. 1979;43(1):360–73.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Lloyd, R.V. (2023). Lung Pathology. In: Pathology: Historical and Contemporary Aspects. Springer, Cham. https://doi.org/10.1007/978-3-031-39554-3_11
Download citation
DOI: https://doi.org/10.1007/978-3-031-39554-3_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-39553-6
Online ISBN: 978-3-031-39554-3
eBook Packages: MedicineMedicine (R0)